EXPERT OPINION ON INVESTIGATIONAL DRUGS

期刊信息导读

1. EXPERT OPINION ON INVESTIGATIONAL DRUGS基本信息
• 2018-2019最新影响因子
• 研究方向
• 官方网站
• 投稿网址
• 年文章数
2. EXPERT OPINION ON INVESTIGATIONAL DRUGS中科院SCI期刊分区
3. 历年EXPERT OPINION ON INVESTIGATIONAL DRUGS影响因子趋势图
4. EXPERT OPINION ON INVESTIGATIONAL DRUGS期刊英文简介
5. EXPERT OPINION ON INVESTIGATIONAL DRUGS期刊中文简介

EXPERT OPINION ON INVESTIGATIONAL DRUGS基本信息

简称：EXPERT OPIN INV DRUG

中文名称：关于研究药物的专家意见

研究方向：医学

2018-2019最新影响因子：4.031

SCI类别：SCIE

是否OA开放访问：No

出版地：ENGLAND

出版周期：Monthly

创刊年份：1994

年文章数：117

涉及的研究方向：医学-药学

通讯方式：INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ

官方网站：http://www.tandfonline.com/toc/ieid20/current

投稿网址：https://mc.manuscriptcentral.com/eoid

审稿速度：较慢,6-12周

平均录用比例:一般

PMC链接：http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1354-3784%5BISSN%5D

EXPERT OPINION ON INVESTIGATIONAL DRUGS期刊英文简介

Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1354-3784.Expert Opinion on Investigational Drugs (EOID) is a monthly peer-reviewed journal, evaluating developments in pharmaceutical research, from animal studies through to the launch of a new medicine. Authors are encouraged to express their Expert Opinion of the status of the research under review, rather than simply reviewing the available data. Each issue of the journal also contains Editorials, Drug Evaluations, Clinical Trial Reports, Meeting Highlights and Paper Evaluations. The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D. Subscribers include most of the major pharmaceutical companies in the USA, Europe and Japan, and many biotechnology companies. Expert Opinion on Investigational Drugs adopts a systematic approach to coverage, with each issue focusing on one of the major therapeutic areas.

EXPERT OPINION ON INVESTIGATIONAL DRUGS期刊中文简介

由Informa Pharmaceutical Science出版(原Ashley Publications)。ISSN: 1354 - 3784。《研究药物专家意见》(EOID)是一份经同行评审的月刊，评估药物研究的进展，从动物研究到新药物的推出。鼓励作者对审查中的研究现状发表专家意见，而不是简单地审查现有数据。每期杂志还包括社论、药物评价、临床试验报告、会议纪要和论文评价。观众包括制药行业的科学家、经理和决策者，以及与研发密切相关的其他人。用户包括美国、欧洲和日本的大多数主要制药公司，以及许多生物技术公司。研究药物的专家意见采用系统的方法进行覆盖，每个问题都集中在一个主要的治疗领域。

中科院SCI期刊分区：

EXPERT OPINION ON INVESTIGATIONAL DRUGS影响因子

获取相关优质资源获取2023中科院分区